A Study of Patients Receiving High-Dose Rate Brachytherapy
Number: NCT00924027
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer
Number: NCT01230866
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Proton Collaborative Group
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer
Number: NCT01581749
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Albert DeNittis|Main Line Health
Sponsor Trial Information
Trial Location(s) and Contact(s) |
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Number: NCT02346253
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Stanford University|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer
Number: NCT02362451
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Diet and Exercise Program to Promote Weight Loss and Improve Health in Men With Low- or Low-Intermediate-Risk Prostate Cancer
Number: NCT02454517
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): Fred Hutchinson Cancer Research Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer
Number: NCT02643667
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Washington University School of Medicine|Pharmacyclics LLC.
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Specialized radiation therapy for Treating Patients With Prostate Cancer
Number: NCT03367702
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): NRG Oncology|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
To learn more about the outcomes and early and late side effects of treating early stage prostate cancer with high dose rate brachytherapy
Number: NCT03424850
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Washington University School of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s) |
PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer
Number: NCT03429244
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Indiana University
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy
Number: NCT03496805
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Wake Forest University Health Sciences
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Study of Rucaparib in Nonmetastatic Prostate Cancer Patients with Genetic Mutations
Number: NCT03533946
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Utah|Clovis Oncology, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s) |
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment
Number: NCT03572387
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Icahn School of Medicine at Mount Sinai
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance
Number: NCT03679260
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Cedars-Sinai Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer
Number: NCT03689582
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Michigan Rogel Cancer Center
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
Number: NCT03716739
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|National Institute on Aging (NIA)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
Number: NCT03735680
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): OncoNano Medicine, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
Number: NCT03769766
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): University of Texas Southwestern Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s) |
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer
Number: NCT03809078
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Andrei Iagaru|General Electric|Stanford University
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy
Number: NCT03821246
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Lawrence Fong|Genentech, Inc.|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s) |
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
Number: NCT03824275
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2| Phase 3
Sponsor(s): Columbia University
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
Number: NCT03860987
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Number: NCT03933670
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of California, San Francisco|National Cancer Institute (NCI)|National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Sponsor Trial Information
Trial Location(s) and Contact(s) |
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer
Number: NCT04147806
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Albert Einstein College of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s) |